UK News Elert

	LATEST BREAKING UK NEWS NICE chief attacks PCTs' inconsistency over funding non-approved medicines NICE chief executive Andrew Dillon has attacked the varying decisions of NHS primary care trusts (PCTs) over appeal decisions to fund non-NICE-recommended drugs in 'exceptional circumstances'. read more Pharma industry rejects NICE chief's profiteering claims The chief of the UK's drug cost-effectiveness watchdog has torn a strip off the pharmaceutical industry saying that the latter's desire for higher profits are driving up prices, a claim drugmakers have been quick to deny read more Oxford BioMedica snubs GeneThera bid and shares soar Oxford BioMedica has turned down takeover bids by the USA's GeneThera, a move which sent its shares soaring and highlights the increased interest of late in biotechnology firms, especially British ones read more Protherics jumps on buyout rumours Shares in UK biotechnology firm Protherics jumped 30% on the London Stock Exchange this morning after the firm revealed it may be entering into acquisition talks read more more stories below UK insurers' new pharma "business interruption" policy The increase in outsourcing by pharmaceutical manufacturers and life sciences companies has created entirely new risks of interruption for their businesses, and UK insurers are now offering protection against these new and changing hazards. read more Cancer patients "cutting back on food, heating" 44% of cancer patients in England are cutting back on food or heating to pay for the cost of their prescriptions, according to a new survey conducted by the charity Macmillan Cancer Support. read more NICE recommends Remicade for UC – but only for some patients The UK's cost-effectiveness agency has published a draft guidance initially recommending drug Remicade for use in England to treat severe acute ulcerative colitis – but only in patients who can not use ciclosporin. read more NHS trusts' quality ratings and funding to be linked to NICE compliance The chair of the new Care Quality Commission, which will regulate UK healthcare from April 2008, has indicated that the commission will come down hard on institutions that do not comply with NICE guidance read more World headlines Amgen stock sinks as FDA calls for stronger warning on Byetta Vioxx study more about marketing than science, says report Clinical headlines WuXi's revenues soar in second quarter Bigger trials may be better for limiting adverse events You have received this mailing because you are part of the PharmaTimes UK News Online mailing list. If you wish to stop receiving these daily mailings please send an e-mail to uk_news-request@pharmatimes.com and type unsubscribe in the subject. Registered in England & Wales at: The Coach House, 173 Sheen Lane, East Sheen, London SW14 8NA Company Registration Number: 2331805 © 2008 PharmaTimes Tel: +44 (0) 20 8878 8566 Fax: +44 (0) 20 8876 8834 www.pharmatimes.com